Germany imported a record amount of marijuana for medical and scientific use in 2022, according to new data from the country’s Federal Institute for Drugs and Medical Devices.
Matt Lamers
Matt Lamers's Latest Posts
Denmark medical cannabis sales mostly on the rise, but pilot program sputters
Denmark’s medical cannabis sales took a breather in 2022 after experiencing consistent growth for half a decade, according to new data from the Danish Health and Medicines Authority.
Cannabis retailer Fire & Flower ends year with CA$89 million loss
Toronto-based cannabis retailer Fire & Flower ended its 2022 fiscal year with a loss of 89.5 million Canadian dollars ($66 million), according to financial and operational results released Tuesday.
Canadian province allows marijuana producers to give samples to stores
Alberta’s cannabis regulator announced a regulatory change that will allow marijuana producers to provide sample products to stores and their representatives.
Aurora Cannabis warned by Nasdaq about low stock price
Aurora Cannabis has been notified by the Nasdaq that it does not meet the stock exchange’s listing standards after its stock price fell below the $1 minimum bid price requirement for 30 days in a row.
Switzerland nears launch of recreational cannabis trial
Switzerland’s government is one step closer to its yearslong effort to launch a trial program involving the sale and consumption of recreational cannabis.
Cannabis producer Hexo trims loss, but sales plummet
Cannabis producer Hexo reported a lower loss for the quarter ended Jan. 31, 2023, but the Gatineau, Quebec-based company’s sales took a nosedive, according to its quarterly report.
Ontario Chamber of Commerce calls on province to allow cannabis lounges
The largest provincial business advocacy body in Canada is calling on the Ontario government to allow cannabis consumption establishments as part of efforts to modernize and champion the sector.
5 Canadian cannabis producers face May deadline in ‘extracts/edibles’ conflict
Health Canada has asked five companies to stop distribution and sale of noncompliant cannabis edibles products by the end of May and provincial wholesalers have been notified of the ongoing crackdown after months of confusion, MJBizDaily has learned.
Indiva pauses some production over cannabis ‘edibles’ dispute
Another Canadian cannabis producer has hit pause on the production of certain products because of a dispute with Health Canada over what constitutes a cannabis “edible.”
Germany confident EU will approve rec cannabis legalization blueprint
German Health Minister Karl Lauterbach has expressed confidence that the country’s plan to legalize recreational cannabis might soon overcome one of its biggest hurdles – European Union approval.
Organigram pauses some cannabis production over classification dispute
Canadian cannabis producer Organigram Holdings said it is pausing production of its lozenge product in a 100-milligram THC package pending a resolution over an ongoing dispute with Health Canada.
